Background Serum α‐fetoprotein (AFP) is the most important tumor marker for
hepatocellular carcinoma (HCC). The reported predictive accuracy of AFP for HCC widely …

Objectives The role of serum α-fetoprotein (AFP) measurements in the diagnosis of
hepatocellular carcinoma (HCC) remains controversial. Some guidelines have advised …

Introduction Alpha‐fetoprotein (AFP) has a valuable role in postoperative surveillance for
hepatocellular carcinoma (HCC) recurrence. The utility of pretreatment or baseline AFP …

The prognostic impact of serum α-fetoprotein (AFP) level in patients with hepatocellular
carcinoma (HCC) is controversial. This study aimed to investigate the predictive ability of …

Background: It is not established whether virological status affects the efficiency of α-
fetoprotein (AFP) as a hepatocellular carcinoma (HCC) marker among patients with chronic …

Background and Aims The prognostic ability of α-fetoprotein (AFP) for patients with
hepatocellular carcinoma (HCC) was examined by using different cutoff values. The optimal …

AIM: To explore the relationship between α-fetoprotein (AFP) and various clinicopathological
variables and different staging system of hepatocellular carcinoma (HCC) thoroughly …

Introduction: serum alpha-fetoprotein (AFP) was routinely employed as a tumor marker for
screening, diagnosis, and treatment follow-up of hepatocellular carcinoma (HCC). However …

BACKGROUND α‐Fetoprotein (AFP) is a biomarker commonly used in the management of
patients with hepatocellular carcinoma (HCC), although the possible determinants of its …

BACKGROUND & AIMS: Current screening algorithms for hepatocellular carcinoma (HCC)
view each testing interval independently, without considering prior test results. We …